DocGo Inc. Segment Reporting Other Item Amount
DocGo Inc. (DCGO) reported Segment Reporting Other Item Amount of $19.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-17
- DocGo Inc. segment reporting other item amount for the quarter ending 2026-06-30 was $19.22M, a 6.83% decline year-over-year.
- DocGo Inc. segment reporting other item amount for the quarter ending 2026-03-31 was $21.16M, a 2.60% increase year-over-year.
- DocGo Inc. segment reporting other item amount for the quarter ending 2025-12-31 was $106.54M, a 267.31% increase year-over-year.
- DocGo Inc. segment reporting other item amount for the quarter ending 2025-09-30 was $37.23M, a 28.08% increase year-over-year.
- DocGo Inc. segment reporting other item amount for fiscal 2025 was $185.03M, a 29.70% increase from fiscal 2024.
- DocGo Inc. segment reporting other item amount for fiscal 2024 was $142.65M, a 6.33% increase from fiscal 2023.
- DocGo Inc. segment reporting other item amount for fiscal 2023 was $134.16M, a 44.89% increase from fiscal 2022.
- DocGo Inc. segment reporting other item amount for fiscal 2022 was $92.60M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.22M 10-Q · filed 2026-08-17 | $40.39M 10-Q · filed 2026-08-17 | $146.93M derived: sum of 3 quarters · filed 2026-08-17 | $184.15M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $21.16M 10-Q · filed 2026-05-11 | $127.70M derived: sum of 2 quarters · filed 2026-05-11 | $164.93M derived: sum of 3 quarters · filed 2026-05-11 | $185.56M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $106.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $143.77M derived: sum of 2 quarters · filed 2026-03-16 | $164.40M derived: sum of 3 quarters · filed 2026-08-17 | $185.03M 10-K · filed 2026-03-16 |
| 2025-09-30 | $37.23M 10-Q · filed 2025-11-10 | $57.86M derived: sum of 2 quarters · filed 2026-08-17 | $78.49M 10-Q · filed 2025-11-10 | $107.49M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $20.63M 10-Q · filed 2026-08-17 | $41.26M 10-Q · filed 2026-08-17 | $70.27M derived: sum of 3 quarters · filed 2026-08-17 | $99.33M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $20.63M 10-Q · filed 2026-05-11 | $49.63M derived: sum of 2 quarters · filed 2026-05-11 | $78.70M derived: sum of 3 quarters · filed 2026-05-11 | $116.20M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $29.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $58.07M derived: sum of 2 quarters · filed 2026-03-16 | $95.57M derived: sum of 3 quarters · filed 2026-03-16 | $142.65M 10-K · filed 2026-03-16 |
| 2024-09-30 | $29.06M 10-Q · filed 2025-11-10 | $66.57M derived: sum of 2 quarters · filed 2025-11-10 | $113.65M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $37.50M 10-Q · filed 2025-08-07 | $84.58M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $47.08M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $134.16M 10-K · filed 2026-03-16 | |||
| 2022-12-31 | $92.60M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |